+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study



Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study



Mayo Clinic Proceedings 79(4): 476-482



To determine whether undiagnosed celiac disease is associated with irritable bowel syndrome (IBS) or dyspepsia in the community. A self-report bowel disease questionnaire was mailed to a random sample of Olmsted County, Minnesota, residents aged 20 to 50 years. All respondents who reported symptoms of dyspepsia or IBS (cases) and all respondents without notable gastrointestinal symptoms (controls) were invited to participate (260 eligible subjects; 150 [58%] were studied). Each respondent was examined by a physician, and the medical records of each were reviewed (3 subjects did not meet the criteria for dyspepsia or IBS at the time of the physician interview). Serum was obtained to measure antiendomysial antibodies and tissue transglutaminase (TTg) IgA antibodies using validated assays. A total of 34 subjects had dyspepsia (20 had ulcerlike dyspepsia), 50 had IBS (19 had diarrhea-predominant IBS), and 15 met criteria for both dyspepsia and IBS; 78 were asymptomatic healthy controls. The overall prevalence of positive TTg serology was 4% (95% confidence interval [CI], 1.5%-8.5%). The number of subjects who were seropositive for TTg was 2 of 34 (5.9%) with dyspepsia (95% CI, 0.7%-19.7%), 2 of 50 (4.0%) with IBS (95% CI, 0.5%-13.7%), and 2 of 78 (2.6%) of asymptomatic controls (95% CI, 03%-9.0%) (P = .64 IBS vs controls; P = .58 dyspepsia vs controls). No subjects had positive antiendomysial antibodies. In this community, celiac disease did not explain the presence of either IBS or dyspepsia.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 048469473

Download citation: RISBibTeXText

PMID: 15065612

DOI: 10.4065/79.4.476


Related references

Celiac disease serology and irritable bowel syndrome: does the relationship merit further evaluation?. Mayo Clinic Proceedings 79(9): 1209-10; Author Reply 1210, 2004

Celiac Disease Serology and Irritable Bowel Syndrome: Does the Relationship Merit Further Evaluation?. Mayo Clinic Proceedings 79(9): 1209-1210, 2004

Prevalence of celiac disease in Indian patients with irritable bowel syndrome and uninvestigated dyspepsia. Journal of Digestive Diseases 16(8): 443-448, 2016

Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study. Digestion 79(3): 196-201, 2009

Sa1282 Celiac Disease, Irritable Bowel Syndrome and Other Functional Gastrointestinal Disorders in a Population-Based Sample - the Silent Affliction?. Gastroenterology 144(5): S-251, 2013

Quality of life at dyspepsia and irritable bowel syndrome: population-based studies. Eksperimental'naia i Klinicheskaia Gastroenterologiia 2010(3): 27-31, 2010

Sa1288 Prevalence of Antibodies Related to Celiac Disease (Cd) in Patients With Irritable Bowel Syndrome (Ibs) According to Rome Iii Criteria. A Case-Control Study. Gastroenterology 144(5): S-252, 2013

Prevalence of celiac disease and related antibodies in patients diagnosed with irritable bowel syndrome according to the Rome III criteria. A case-control study. Neurogastroenterology and Motility 28(7): 994-1000, 2018

Inflammatory bowel disease versus irritable bowel syndrome: A hospital-based, case-control study of disease impact on quality of life. Scandinavian Journal of Gastroenterology 38(10): 1031-1038, 2003

Dyspepsia and irritable bowel syndrome in China: a population-based endoscopy study of prevalence and impact. Alimentary Pharmacology and Therapeutics 32(4): 562-572, 2011

Evidence that the irritable bowel syndrome and functional dyspepsia are a single disorder A longitudinal, population-based study. Gastroenterology 110(4 SUPPL ): A26, 1996

Somatization an independent psychosocial risk factor for irritable bowel syndrome but not dyspepsia: a population-based study. European Journal of Gastroenterology and Hepatology 18(10): 1101-1109, 2006

Self-rated health and functional capacity in individuals reporting overlapping symptoms of gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome - a population based study. Bmc Gastroenterology 17(1): 65, 2018

Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population. Scandinavian Journal of Gastroenterology 50(2): 162-169, 2015

Racial differences in epidemiology of irritable bowel syndrome alone, un-investigated dyspepsia alone, and "overlap syndrome" among african americans compared to Caucasians: a population-based study. Digestive Diseases and Sciences 51(1): 218-226, 2006